UH15-38

UH15-38
Clinical data
Other names	HY-158312
Identifiers
	IUPAC name 3-(3-hydroxyphenyl)-1-methyl-7-[3-(4-methylpiperazin-1-yl)anilino]-1,6-naphthyridin-2-one ;
CAS Number	2540881-21-6;
PubChem CID	155288621;
Chemical and physical data
Formula	C26H27N5O2
Molar mass	441.535 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCN(CC1)C2=CC=CC(=C2)NC3=NC=C4C=C(C(=O)N(C4=C3)C)C5=CC(=CC=C5)O;
	InChI InChI=1S/C26H27N5O2/c1-29-9-11-31(12-10-29)21-7-4-6-20(15-21)28-25-16-24-19(17-27-25)14-23(26(33)30(24)2)18-5-3-8-22(32)13-18/h3-8,13-17,32H,9-12H2,1-2H3,(H,27,28); Key:DLRROFRAOBFFEP-UHFFFAOYSA-N;

UH15-38 is an experimental RIPK3 inhibitor being studied as a potential treatment for influenza.